Both Neutrogena T/Gel and Leflunomide offer similar effectiveness, with differences in speed and duration of relief.

Neutrogena T/Gel has fewer side effects and is less likely to interact with other medications.

Both drugs are low-risk for addiction when used properly, with minimal potential for misuse.

Neutrogena T/Gel has a simple once-daily dose, making it easier to stick to a treatment routine.

Neutrogena T/Gel has fewer contraindications, making it suitable for patients with multiple health conditions.

Neutrogena T/Gel is ideal for fast relief, ease of use, and lower addiction risk, making it best for acute symptoms.